# A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007)

> **NCT00907738** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 27 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** vorinostat

## Key facts

- **NCT ID:** NCT00907738
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2015-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907738, "A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00907738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*